Showing results (231-240 of 554) with videos related to
Sort By:
Pageof 56
Scandinavian Journal of Immunology|November 7, 2006
Identification and characterization of secretagogin promoter activityK V Skovhus, R Bergholdt, C Erichsen, et al.Cytokine|August 1, 1997
Dexamethasone prevents interleukin-1beta-mediated inhibition of rat islet insulin secretion without decreasing nitric oxide productionD Mauricio, H U Andersen, C M Larsen, et al.Ugeskrift for Laeger|June 10, 1991
[Systemic lupus erythematosus. 1. Disease manifestations, infections, thrombotic episodes, causes of death and survival in a case load of 173 patients followed for 13.9 years]P Halberg, G Bendixen, N J Kriegbaum, et al.Scandinavian Journal of Rheumatology|January 1, 1982
Functional characteristics of synovial fluid and blood mononuclear cells in rheumatoid arthritis and traumatic synovitisJ Petersen, V Andersen, G Bendixen, et al.The Journal of Investigative Dermatology|October 1, 1983
Lymphocyte function and chromosome aberrations in patients with early mycosis fungoides and parapsoriasis en plaquesO J Clemmensen, K Bendtzen, V Andersen, et al.Acta Endocrinologica|October 1, 1988
The bimodal effect of interleukin 1 on rat pancreatic beta-cells--stimulation followed by inhibition--depends upon dose, duration of exposure, and ambient glucose concentrationG A Spinas, J P Palmer, T Mandrup-Poulsen, et al.Acta Medica Scandinavica|January 1, 1982
Neutrophil and lymphocyte function in patients with diabetes mellitusN H Valerius, C Eff, N E Hansen, et al.Diabetes|December 2, 1999
Beta-cell maturation leads to in vitro sensitivity to cytotoxinsK Nielsen, A E Karlsen, M Deckert, et al.Diabetes Care|March 31, 1999
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up studyH H Parving, L Tarnow, F S Nielsen, et al.Progress in Clinical and Biological Research|January 1, 1982
HLA and diabetesA Svejgaard, M Christy, A Green, et al.Pageof 56